Custody, keys and concessions: digital assets in Hong Kong family office and trust structures—property, private keys, fiduciary duty and the price of the licensed intermediary, with English, offshore and Singapore perspectives
Trusts & Trustees · 03.11.2026
DOI: 10.1093/tandt/ttag079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trusts & Trustees, online erschienen am 03.11.2026. Verfasst von Alexander Ressos.
Abstract (Originalsprache)
In three years, Hong Kong has built a regulatory and fiscal architecture for digital assets reaching every layer of the private wealth structure. This article argues that the private key, not the token, is the operative subject matter of the digital-asset trust: constitution, certainty of subject matter, custody, delegation, exoneration and succession must all be restated in terms of who can sign. Hong Kong’s concessions, fiscal and regulatory alike, are the price the state pays to move key control into supervised hands; the settlor who declines that bargain keeps a structure more fragile than its documentation suggests.
Zitieren
APA
Ressos, A. (2026). Custody, keys and concessions: digital assets in Hong Kong family office and trust structures—property, private keys, fiduciary duty and the price of the licensed intermediary, with English, offshore and Singapore perspectives. Trusts & Trustees. https://doi.org/10.1093/tandt/ttag079
Vancouver
Ressos A. Custody, keys and concessions: digital assets in Hong Kong family office and trust structures—property, private keys, fiduciary duty and the price of the licensed intermediary, with English, offshore and Singapore perspectives. Trusts & Trustees. 2026. doi:10.1093/tandt/ttag079
BibTeX
@article{Ressos2026,
author = {Ressos, Alexander},
title = {Custody, keys and concessions: digital assets in Hong Kong family office and trust structures—property, private keys, fiduciary duty and the price of the licensed intermediary, with English, offshore and Singapore perspectives},
journal = {Trusts & Trustees},
year = {2026},
doi = {10.1093/tandt/ttag079}
}
EUVIMED